Related Experiment Video
Updated: Feb 16, 2026

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile
Published on: June 13, 2016
Exosomal small RNA sequencing uncovers the microRNA dose markers for power frequency electromagnetic field exposure
Hualiang Li1, Lin Lin2, Li Li1
1a Electric Power Research Institute of Guangdong Power Grid , Guangzhou , PR China.
Purpose:
The potential health risks caused by power frequency electromagnetic field (PFEMF) have led to increase public health concerns. However, the diagnosis and prognosis remain challenging in determination of exact dose of PFEMF exposure.
Materials And Methods:
Mice were exposed to different magnetic doses of PFEMF for the following isolation of serum exosomes, microRNAs (miRNAs) extraction and small RNA sequencing. After small RNA sequencing, bioinformatic analysis, quantitative real-time PCR (qRT-PCR) validation and serum exosomal miRNA biomarkers were determined.
Results:
Significantly changed serum exosomal miRNA as biomarkers of 0.1, 0.5, 2.5 mT and common PFEMF exposure were confirmed. Gene ontology (GO) and Kyoto encyclopaedia of genes and genomes (KEGG) pathway analysis of the downstream target genes of the above-identified exosomal miRNA markers indicated that, exosomal miRNA markers were predicted to be involved in critical pathophysiological processes of neural system and cancer- or other disease-related signalling pathways.
Conclusions:
Aberrantly-expressed serum exosomal miRNAs, including miR-128-3p for 0.1 mT, miR-133a-3p for 0.5 mT, miR-142a-5p for 2.5 mT, miR-218-5p and miR-199a-3p for common PFEMF exposure, suggested a series of informative markers for not only identifying the exact dose of PFEMF exposure, also consolidating the base for future clinical intervention.
Insights
Power frequency electromagnetic field (PFEMF) exposure poses health risks, but dose determination is difficult. This study identified specific serum exosomal microRNAs (miRNAs) as biomarkers to accurately assess PFEMF exposure levels in mice.
Area of Science:
- Biomedical Science
- Environmental Health
- Molecular Biology
Background:
- Power frequency electromagnetic field (PFEMF) exposure is a growing public health concern.
- Accurate diagnosis and prognosis of PFEMF exposure effects are challenging due to difficulties in determining precise exposure doses.
- Biomarkers are needed to quantify PFEMF exposure and its health implications.
Purpose of the Study:
- To identify reliable biomarkers for determining the exact dose of PFEMF exposure.
- To investigate the potential health risks associated with different PFEMF exposure levels.
- To establish a foundation for future clinical interventions related to PFEMF exposure.
Main Methods:
- Mice were exposed to varying doses of PFEMF.
- Serum exosomes were isolated, and microRNAs (miRNAs) were extracted and sequenced.
- Bioinformatic analysis, including Gene Ontology and KEGG pathway analysis, and qRT-PCR were used to identify and validate miRNA biomarkers.
Main Results:
- Specific serum exosomal miRNAs were identified as significant biomarkers for different PFEMF exposure doses (0.1, 0.5, 2.5 mT) and common exposure.
- Pathway analysis indicated that these miRNA markers are involved in crucial neural system pathophysiological processes.
- The identified markers are predicted to play roles in cancer and other disease-related signaling pathways.
Conclusions:
- Aberrantly expressed serum exosomal miRNAs, such as miR-128-3p, miR-133a-3p, miR-142a-5p, miR-218-5p, and miR-199a-3p, serve as informative markers for PFEMF exposure.
- These miRNA biomarkers can help identify the exact dose of PFEMF exposure.
- The findings provide a basis for future clinical interventions aimed at mitigating PFEMF-related health risks.
Related Concept Videos
Electromagnetic Fields
However, the observation of...
MicroRNAs
MicroRNAs
The Electromagnetic Spectrum
The Electromagnetic Spectrum
Dose Size and Dosing Frequency: Determination Methods

